LDHA - Lactate Dehydrogenase A | Elisa - Clia - Antibody - Protein

Background:

Lactate dehydrogenase A (LDHA) is an enzyme that catalyzes the reversible conversion of pyruvate to lactate during anaerobic glycolysis. It is a tetrameric enzyme composed of four subunits, each containing a binding site for the coenzyme nicotinamide adenine dinucleotide (NADH/NAD⁺). LDHA is predominantly expressed in muscle tissues, including skeletal muscle, where it plays a crucial role in energy metabolism. LDHA catalyzes the final step of anaerobic glycolysis, the conversion of pyruvate to lactate. This process is essential for generating ATP under anaerobic conditions when oxygen availability is limited.LDHA is involved in the maintenance of cellular redox balance by converting NADH to NAD⁺ during the reduction of pyruvate to lactate. This reaction helps to regenerate NAD⁺, which is necessary for glycolysis to continue in the absence of oxygen.By facilitating the conversion of pyruvate to lactate, LDHA contributes to the production of ATP, albeit less efficiently than aerobic respiration. This allows cells to meet their energy demands, particularly during periods of high energy expenditure or oxygen limitation. Dysregulation of LDHA has been implicated in various pathological conditions, including tissue damage, ischemia-reperfusion injury, and neurodegenerative diseases. Excessive lactate accumulation due to LDHA dysregulation can contribute to tissue acidosis, oxidative stress, and inflammation, leading to cellular damage and dysfunction .LDHA is often upregulated in cancer cells as part of a metabolic adaptation known as the Warburg effect, where cancer cells preferentially rely on glycolysis for energy production even in the presence of oxygen. Elevated LDHA expression contributes to increased lactate production, which can promote tumor growth, invasion, and metastasis.

Protein Structure:

LDHA is a polypeptide composed of 332 amino acids, with a molecular weight of approximately 36 kDa. It functions as a tetramer, with each subunit contributing to the overall enzymatic activity. The structure of LDHA includes:

• Active Site: The region where pyruvate binds and is converted to lactate.
• NADH Binding Site: The site where NADH binds to facilitate the transfer of electrons during the conversion process.

Classification and Subtypes:

LDHA is one of five isoenzymes of lactate dehydrogenase (LDH), which also includes LDHB, LDHC, LDHD, and LDHE. These isoenzymes form different tetrameric combinations depending on the tissue type, such as:

• LDH-1 (H4): Predominantly found in the heart.
• LDH-2 (H3M1): Common in reticuloendothelial system.
• LDH-3 (H2M2): Found in the lungs.
• LDH-4 (H1M3): Found in the kidneys.
• LDH-5 (M4): Predominantly found in the liver and muscles, with LDHA being the main component.

Function and Biological Significance:

• Energy Production: LDHA facilitates anaerobic glycolysis, allowing ATP production in the absence of oxygen.
• Metabolic Adaptation: In rapidly growing tissues and tumors, LDHA helps adapt to hypoxic conditions by promoting lactate production, which can be used for energy and biosynthesis.
• Warburg Effect: In cancer cells, LDHA is upregulated to support the Warburg effect, where cancer cells preferentially produce energy through glycolysis followed by lactic acid fermentation even in the presence of oxygen.

Interactions:

• Pyruvate: LDHA converts pyruvate to lactate in the final step of anaerobic glycolysis.
• NADH: LDHA uses NADH as a cofactor, oxidizing it to NAD+ during the conversion of pyruvate to lactate.
• Other Glycolytic Enzymes: LDHA works in concert with other enzymes in the glycolytic pathway to ensure a continuous supply of ATP under anaerobic conditions.

Clinical Issues:

• Cancer: Elevated levels of LDHA are often associated with various cancers, making it a potential biomarker for tumor progression and prognosis. Inhibitors of LDHA are being explored as potential anticancer therapies.
• Muscle Disorders: Mutations or deficiencies in LDHA can lead to muscle disorders characterized by impaired glycolysis and energy production, resulting in muscle weakness and cramping.
• Heart and Liver Disease: Abnormal LDHA levels can also indicate damage to tissues such as the heart and liver, where different isoforms of LDH are predominant.

Summary:

LDHA is a critical enzyme in anaerobic glycolysis, facilitating the conversion of pyruvate to lactate and enabling ATP production in the absence of oxygen. It plays a significant role in various physiological and pathological processes, particularly in rapidly growing tissues and tumors. LDHA serves as a potential biomarker for cancer and other diseases, and its inhibition is being investigated as a therapeutic strategy.